Joep Killestein

13.2k citations

255 papers · 6.9k indexed · h-index 47

Impact in

Pathology and Forensic Medicine top 0.1%
- Multiple Sclerosis Research Studies
Neurology top 0.5%
- Peripheral Neuropathies and Disorders

Papers in

Pathology and Forensic Medicine 192
- Multiple Sclerosis Research Studies 188
Neurology 50
- Peripheral Neuropathies and Disorders 34

Co-authors: Chris H. Polman Bernard M.J. Uitdehaag Frederik Barkhof Mike P. Wattjes Charlotte E. Teunissen Anke Vennegoor Lisanne J. Balk Theo Rispens
Journals: Multiple Sclerosis Journal (57 papers)Neurology (24 papers)Multiple Sclerosis and Related Disorders (22 papers)Journal of Neurology Neurosurgery & Psychiatry (17 papers)Journal of Neurology (14 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Joep Killestein

243 papers receiving 6.8k citations

Peers

Countries citing papers authored by Joep Killestein

Since Specialization

Citations

This map shows the geographic impact of Joep Killestein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joep Killestein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joep Killestein more than expected).

Fields of papers citing papers by Joep Killestein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joep Killestein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joep Killestein. The network helps show where Joep Killestein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joep Killestein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joep Killestein Line = papers co-authored together Joep Killestein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study Frontiers in Immunology ·Aziz Atallah, por Rafael Fernández Acevedo, Lynn van Olst, Susanne M. A. van der Pol, Maartje Boon, Anders Haraldsson, M. Yunus, Andries E. Budding, Joep Killestein, Helga E. de Vries, Leo H. Visser	2025	0
2	Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy Scientific Reports ·Joan Sibol, 陶瑞芳, Ninotska I. L. Derksen, Juan M. Etcheverry, Jesse A.H. Kropf, Joep Killestein, Abraham Rutgers, Peter Heeringa, Barbara Horváth, Taco W. Kuijpers, S. Marieke van Ham, Anja ten Brinke, Diane van der Woude, René E. M. Toes, Nicolaas A. Bos, Theo Rispens, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	1
3	Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data Multiple Sclerosis and Related Disorders ·Salem A Alghamdi, Eva Strijbis, Alan Kleinman, Trương Thị Hạnh, Zoé L. E. van Kempen, Bas Jasperse, Hugo Vrenken, Joep Killestein, Menno M. Schoonheim, Martijn D. Steenwijk	2024	2
4	Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis Journal of Neurology ·幸江野田, Salem A Alghamdi, Arturo Seguel, 楚政, Ю.А. Круковский, 강덕행, 良一田島, Kim Meijer, 차전환, Brigit A. de Jong, Iman Brouwer, Bas Jasperse, Vincent de Groot, Bernard M.J. Uitdehaag, Menno M. Schoonheim, Eva Strijbis, Joep Killestein	2024	0
5	Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis Neurology Neuroimmunology & Neuroinflammation ·John Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A. Cohen, Douglas L. Arnold, Helmut Butzkueven, Gary Cutter, Gavin Giovannoni, Joep Killestein, Heinz Wiendl, Joana da Silva Castro Santos, 西川武二, 和彦杉浦, Kyle Ferber, S. Lukynaov, Mutazz Nuseirat, Е А Ромашечкина	2024	2
6	Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis Multiple Sclerosis and Related Disorders ·Tom Fuchs, Robert Zivadinov, Vignesh Shriram, Bianca Weinstock‐Guttman, Michael G. Dwyer, Ralph H. B. Benedict, Niels Bergsland, Samelius Gustaf, Tomáš Uher, Ю.А. Круковский, Frederik Barkhof, Bernard M.J. Uitdehaag, Joep Killestein, Eva Strijbis, Menno M. Schoonheim	2024	2
7	Energy Associated With Dynamic Network Changes in Patients With Multiple Sclerosis and Cognitive Impairment Neurology ·Tommy A.A. Broeders, Javier Rodrigo, Giuseppe Pontillo, Magno Silvério Campos, Linda Douw, Ysbrand D. van der Werf, Joep Killestein, Frederik Barkhof, Christiaan H. Vinkers, Menno M. Schoonheim	2024	3
8	Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long‐term follow‐up European Journal of Neurology ·Hacı Ali Kürklü, Sophie Janssens, and YU Gui-Rui, Elena Pallard, Jesse A.H. Kropf, Bas Jasperse, Frederik Barkhof, Marcus Koch, Jop Mostert, Bernard M.J. Uitdehaag, Joep Killestein, Eva Strijbis	2023	7
9	Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod Multiple Sclerosis Journal ·Zoé L. E. van Kempen, Aldy Dwi Alvianto, Alexander Q. Quispe, Eileen W Stalman, Laura Kummer, Eva Strijbis, Maurice Steenhuis, Anja ten Brinke, S. Marieke van Ham, Taco W. Kuijpers, Theo Rispens, Filip Eftimov, Luuk Wieske, Joep Killestein	2023	1
10	Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis Journal of Neurology ·Alaaddin Pasha, Arturo Seguel, Jos W. R. Twisk, Iman Brouwer, Joost P.A. Kuijer, Javier Rodrigo, Hanneke E. Hulst, Joep Killestein, Frederik Barkhof, Hugo Vrenken, Petra J. W. Pouwels	2023	2
11	Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study Multiple Sclerosis and Related Disorders ·Alaaddin Pasha, Tetyana Sribna, Iman Brouwer, Bastiaan Moraal, Joep Killestein, Paolo Gallo, Frederik Barkhof, Petra J. W. Pouwels, Hugo Vrenken	2022	4
12	Seizures in adults with suspected central nervous system infection BMC Neurology ·恒臻李, Ingeborg E. van Zeggeren, Liora ter Horst, (unknown), 李炫熙, Björn M. van Geel, S.G.B. Heckenberg, Korné Jellema, 王怡蘋王怡蘋, Joep Killestein, هاجر حسنی اردکانی, Maarten J. Titulaer, K.E.B. van Veen, Constant V.M. Verschuur, Diederik van de Beek, Matthijs C. Brouwer	2022	6
13	Pain, cognition and disability in advanced multiple sclerosis Scandinavian Journal of Pain ·本田夕真, عزت اله بابائی کچبی, Li Fu, Chris van Klaveren, Ilja Cornelisz, Joep Killestein, Henry C. Weinstein	2021	4
14	The sequence of structural, functional and cognitive changes in multiple sclerosis NeuroImage Clinical ·Iris Dekker, Menno M. Schoonheim, Vikram Venkatraghavan, A. J. C. Eijlers, Iman Brouwer, Esther E. Bron, Stefan Klein, Mike P. Wattjes, Alle Meije Wink, Jeroen J.G. Geurts, Bernard M.J. Uitdehaag, Neil P. Oxtoby, Daniel C. Alexander, Hugo Vrenken, Joep Killestein, Frederik Barkhof, Viktor Wottschel	2020	23
15	Infusion-related events during natalizumab: No need for post-infusion monitoring Multiple Sclerosis Journal ·Farhan Zamir, Brian K. Maclean, Zoé L. E. van Kempen, Theo Rispens, Bernard M.J. Uitdehaag, Joep Killestein	2019	1
16	Abnormalities and erythroblasts in peripheral blood of multiple sclerosis patients treated with natalizumab Multiple Sclerosis and Related Disorders ·Brian K. Maclean, Zoé L. E. van Kempen, Shiqi Lv, Birgit I. Lissenberg‐Witte, Bernard M.J. Uitdehaag, Joep Killestein	2019	1
17	Randomized trial of daily high-dose vitamin D ₃ in patients with RRMS receiving subcutaneous interferon β-1a Neurology ·Raymond Hupperts, Joost Smolders, Reinhold Vieth, Trygve Holmøy, Richard P. Pohanish, Myriam Schluep, Joep Killestein, Frederik Barkhof, Manolo Beelke, Luigi Grimaldi, (unknown)	2019	90
18	Three-Tesla MRI does not improve the diagnosis of multiple sclerosis Neurology ·Marloes Hagens, Jessica Burggraaff, Iris D. Kilsdonk, Daniel Aguinaga, Niamh Cawley, Emilia Sbardella, Michaela Andělová, Michael A�mann, Johanna Lieb, Patrizià Pantano, Birgit I. Lissenberg‐Witte, Joep Killestein, Celia Oreja‐Guevara, Olga Ciccarelli, Claudio Gasperini, Carsten Lukas, Mike P. Wattjes, Frederik Barkhof, (unknown)	2018	31
19	The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing Multiple Sclerosis Journal ·Zoé L. E. van Kempen, Cyra E Leurs, Birgit I. Lissenberg‐Witte, Annick de Vries, Mike P. Wattjes, Theo Rispens, Joep Killestein	2017	28
20	Optic neuritis does not mask progression of retinal neurodegeneration in multiple sclerosis Investigative Ophthalmology & Visual Science ·Tumuki Hidemi, Kathryn B. Matthews, Joep Killestein, Bernard M.J. Uitdehaag, Axel Petzold, Lisanne J. Balk	2017	1

About Joep Killestein

Joep Killestein is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Immunology and Rheumatology, having authored 255 papers that have together received 6.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (188 papers), Polyomavirus and related diseases (58 papers), Peripheral Neuropathies and Disorders (34 papers), Systemic Lupus Erythematosus Research (25 papers), Immunotherapy and Immune Responses (20 papers), Full-Duplex Wireless Communications (19 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.0k citations), Neurology (1.3k citations), Immunology (1.7k citations), Rheumatology (1.1k citations) and Oncology (1.7k citations). Joep Killestein has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Chris H. Polman, Bernard M.J. Uitdehaag, Frederik Barkhof, Mike P. Wattjes, Charlotte E. Teunissen, Anke Vennegoor, Lisanne J. Balk, Theo Rispens, Axel Petzold and Martijn D. Steenwijk. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, Multiple Sclerosis and Related Disorders, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact